A Study Investigating SGI-110 in Combination With Ipilimumab in Unresectable or Metastatic Melanoma Patients
Clinical trial NCT02608437 · UNKNOWN
Trial details
- NCT number
- NCT02608437
- Sponsor
- Italian Network for Tumor Biotherapy Foundation
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2016-10-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.